Skip to main content
    M

    Microbot Medical Inc (MBOT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.95
    -0.04 (-4.19%)

    Market Cap: $68.51M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(21/35)
    Avg Surprise
    +1.27%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    3 analysts
    EPS Revisions
    1
    0
    7d
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.080.0%
    60d ago$-0.07-9.1%
    30d ago$-0.08+4.0%
    7d ago$-0.080.0%
    Current$-0.08
    Revenue Consensus
    $416670
    Range$250000 - $600000
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.08 - $-0.06
    3 analysts
    Revenue Consensus
    $82000
    Range$-320670 - $583330
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.08---
    Jun 26
    Reported Aug 11
    		$-0.08$-0.08+0.00%Beat+20.0%
    Mar 26
    Reported May 13
    		$-0.05$-0.08+37.50%Beat+37.5%
    Dec 25
    Reported Mar 26
    		$-0.04$-0.06+33.33%Beat+80.0%
    Sep 25
    Reported Nov 12
    		$-0.07$-0.06-16.67%Miss+65.0%
    Jun 25
    Reported Aug 12
    		$-0.10$-0.08-25.00%Miss+41.2%
    Mar 25
    Reported May 14
    		$-0.08$-0.13+38.46%Beat+52.9%
    Dec 24
    Reported Mar 25
    		$-0.20$-0.18-11.11%Miss+23.1%
    Sep 24
    Reported Nov 13
    		$-0.20$-0.17-17.65%Miss+4.8%
    Jun 24
    Reported Aug 14
    		$-0.17$-0.17+0.00%Beat+32.0%
    Mar 24
    Reported May 15
    		$-0.17$-0.17+0.00%Beat+52.8%
    Dec 23
    Reported Mar 27
    		$-0.26$-0.25-4.00%Miss+31.6%
    Sep 23
    Reported Nov 14
    		$-0.21$-0.25+16.00%Beat+57.1%
    Jun 23
    Reported Aug 14
    		$-0.25$-0.31+19.35%Beat+49.0%
    Mar 23
    Reported May 17
    		$-0.36$-0.45+20.00%Beat+20.0%
    Dec 22
    Reported Mar 29
    		$-0.38$-0.47+19.15%Beat+29.6%
    Sep 22
    Reported Nov 14
    		$-0.49$-0.51+3.92%Beat-36.1%
    Jun 22
    Reported Aug 15
    		$-0.49$-0.45-8.89%Miss-40.0%
    Mar 22
    Reported May 16
    		$-0.45$-0.42-7.14%Miss-32.4%
    Dec 21
    Reported Mar 31
    		$-0.54$-0.37-45.95%Miss-45.9%
    Sep 21
    Reported Nov 15
    		$-0.36$-0.36+0.00%Beat-2.9%
    Jun 21
    Reported Aug 16
    		$-0.35$-0.35+0.00%Beat-34.6%
    Mar 21
    Reported May 17
    		$-0.34$-0.33-3.03%Miss-9.7%
    Dec 20
    Reported Mar 31
    		$-0.37$-0.34-8.82%Miss-12.1%
    Sep 20
    Reported Nov 16
    		$-0.35$-0.28-25.00%Miss+20.5%
    Jun 20
    Reported Aug 14
    		$-0.26$-0.27+3.70%Beat+27.8%
    Mar 20
    Reported Apr 14
    		$-0.31$-0.28-10.71%Miss+35.4%
    Dec 19
    Reported Mar 26
    		$-0.33$-0.33+0.00%Beat+54.2%
    Sep 19
    Reported Nov 14
    		$-0.44$-0.44+0.00%Beat+24.1%
    Jun 19
    Reported Aug 14
    		$-0.36$-0.45+20.00%Beat+40.0%
    Mar 19
    Reported Apr 1
    		$-0.48$-0.42-14.29%Miss-6.7%
    Dec 18
    Reported Mar 31
    		$-0.72$-0.59-22.03%Miss-2300.0%
    Sep 18
    Reported Nov 14
    		$-0.58$-0.60+3.33%Beat-28.9%
    Jun 18
    Reported Aug 14
    		$-0.60$-0.60+0.00%Beat-566.7%
    Mar 18
    Reported Apr 2
    		$-0.45$-0.60+25.00%Beat+25.0%
    Dec 17
    Reported Mar 22
    		$-0.03$-0.04+25.00%Beat-
    Sep 17
    Reported Nov 14
    		$-0.45N/AN/ABeat-
    Jun 17
    Reported Aug 14
    		$-0.09N/AN/ABeat-
    Mar 17
    Reported May 15
    		$-0.60$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-3.96EV/EBITDAN/A
    Price/FCF-3.56xFCF Yield-28.10%
    Profitability
    Profit Margin0.00%Operating Margin-2568.00%
    ROE-32.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio18.56xQuick Ratio17.82x
    Trading Statistics
    Beta1.05Avg Volume735.64K
    52-Week High$2.8952-Week Low$0.99

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.06
    SMA 20$1.17
    SMA 50$1.39
    SMA 200$1.91
    EMA 10$1.06
    EMA 20$1.16
    EMA 50$1.35
    EMA 200$1.83

    MACD

    Line: -0.12Signal: -0.11Hist: -0.01

    ADX

    ADX: 58.5+DI: 3.2-DI: 35.5

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$1.07

    Bollinger Bands

    Upper Band$1.44
    Lower Band$0.91
    %B Position4557%(Upper)
    Band Width0.08

    RSI (14-Day)

    Oversold
    16.6

    Momentum Oscillators

    Stoch %K3.6
    Stoch %D3.5
    Williams %R-94.3
    ROC (10d)-20.8%
    Momentum-0.25
    CCI (20d)-131.6
    MFI (14d)22.7

    Volatility Measures

    ATR (14d)$0.06(6.8%)
    StdDev (20d)0.13
    Hist Vol44.1%(High)

    Volume Flow

    VWAP$0.96
    OBV21.2M
    AD Line-43.3M
    CMF (20d)-0.383

    Volume Metrics

    Avg Vol (20d)775.3K
    Vol Ratio1.8x(High)
    VWMA (20d)$1.15

    Pivot Points

    R3$1.06
    R2$1.04
    R1$1.02
    Pivot Point$1.00
    S1$0.98
    S2$0.96
    S3$0.94

    Advanced Oscillators

    TSI-58.58
    Ultimate Osc29.8
    KST-252.44

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$241,000$105,000$0$0$0$0$84,000$0$0$0$142,000$0
    Cost of Revenue$884,000$103,000$10,000$0$0$0$26,000$0$0$0$35,000$0
    Gross Profit$-643,000$2,000$-10,000$0$0$0$-26,000$0$0$0$-35,000$0
    Operating Expenses$5.54M$4.32M$4.14M$3.86M$3.72M$3.02M$3.43M$3.30M$2.51M$2.38M$2.07M$2.54M
    R&D$1.86M$1.29M$1.54M$1.17M$2.11M$1.46M$1.98M$2.06M$1.42M$1.17M$1.13M$1.61M
    SG&A$3.68M$3.03M$2.60M$2.69M$1.61M$1.56M$1.45M$1.24M$1.09M$1.22M$938,000$932,000
    Operating Income$-6,188,000$-4,320,000$-4,138,000$-3,861,000$-3,723,000$-3,021,000$-3,430,000$-3,300,000$-2,511,000$-2,384,000$-2,068,000$-2,544,000
    Interest Income$561,000$649,000$674,000$284,000$223,000$104,000$38,000$85,000$46,000$13,000$27,000$98,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$1.08M$0
    Income Before Tax$-5,627,000$-3,671,000$-3,464,000$-3,577,000$-3,500,000$-2,601,000$-3,392,000$-3,215,000$-2,465,000$-2,371,000$-3,152,000$-2,446,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,627,000$-3,671,000$-3,464,000$-3,577,000$-3,500,000$-2,601,000$-3,392,000$-3,215,000$-2,465,000$-2,371,000$-3,154,000$-2,446,000
    EBITDA$-6,173,000$-4,308,000$-4,128,000$-3,851,000$-3,711,000$-2,690,000$-3,404,000$-3,277,000$-2,497,000$-2,356,000$-2,033,000$-2,524,000
    EBIT$-6,188,000$-4,320,000$-4,138,000$-3,861,000$-3,723,000$-2,705,000$-3,430,000$-3,300,000$-2,511,000$-2,384,000$-2,068,000$-2,544,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MBOT

    News

    Microbot Medical stock at USD 0.95, 2.15 percent above its 52-week low

    Microbot Medical (MBOT) stock is trading at USD 0.95, which is 2.15 percent above its 52-week low of USD 0.93. The company's second-quarter revenue reached USD 0.24 million...

    ad-hoc-news.de•10/15/26•Neutral

    Microbot Medical Inc. (CY9D.DU) stock price, news, quote and history

    The article provides a snapshot of Microbot Medical Inc. (CY9D.DU) stock information, including its current price, daily change, and a decline of 7.13%. It also offers links to news, charts, statistics, historical data...

    Yahoo Finance UK•10/15/26•Bearish

    AltIndex assigns Hold to Microbot Medical stock at USD 1.06 target

    AltIndex has assigned a "Hold" rating to Microbot Medical (MBOT) stock with a six-month price target of USD 1.06. This AI-driven forecast comes as the company transitions from product development to commercialization...

    AD HOC NEWS•10/8/26•Neutral

    Microbot Medical Secures Israeli Distribution Deal for LIBERTY

    Microbot Medical Inc. announced a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell its LIBERTY Endovascular Robotic System in Israel. This deal follows regulatory approval in May 2026...

    The Globe and Mail•10/7/26•Bullish

    An Israeli distributor gets exclusive rights to sell a robot for blood-vessel procedures.

    Microbot Medical (MBOT) has signed a three-year exclusive distribution agreement with Medtechnica Ltd. to commercialize and sell its LIBERTY Endovascular Robotic System in Israel. The system received Israeli regulatory...

    Stock Titan•10/7/26•Bullish

    MBOT Valuation and Fair Value

    P/E
    -4.0x
    Forward P/E
    31.8x
    P/FCF
    -3.6x
    PEG
    0.7x
    P/B
    0.9x
    See GNG's fair value

    MBOT Profitability: Margins, ROIC and FCF

    Operating margin
    -2568.0%
    Net margin
    0.0%
    ROE
    -32.9%
    FCF margin
    -5181.8%
    FCF yield
    -28.1%

    MBOT Competitors

    CompanyTicker
    Cingulate IncCING
    Spero Therapeutics IncSPRO
    Heron TherapeutiHRTX
    Champions Oncology IncCSBR
    Fortress Biotech IncFBIO
    Neumora Therapeutics, Inc.NMRA
    Coeptis Therapeutics IncCOEP
    XBiotech IncXBIT

    Sector: Healthcare

    MBOT Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    MBOT Bull Case vs Bear Case

    Bear case

    • MBOT beat EPS estimates in 37.5% of its last 8 reported quarters.

    MBOT Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    4.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.08
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About MBOT

    Does MBOT pay dividends?

    Microbot Medical Inc (MBOT) does not currently pay a regular dividend.

    What is MBOT's market cap?

    Microbot Medical Inc (MBOT) has a market capitalization of $68.51M with a current stock price of $0.95.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In